Multiple sclerosis (MS) is a neurological disease that affects over 100,000 Canadians and is the leading cause of neurological disability amongst people ages 20-40 years. It is associated with progressive disability in terms of motor, visual, sensory, autonomic and cognitive function. MS costs Canadians economically too, approaching almost a billion dollars per year concerning costs to the healthcare system. Moreover, MS is on the rise in Canada, with growing prevalence and incidence, predominantly amongst women, although it is increasingly recognized in groups not previously thought to be susceptible to MS including First Nations and new Canadians of non-Caucasian background. For these reasons, MS has been dubbed “Canada’s disease” by Macleans (April 27, 2015). Our Laboratory is interested in multiple different aspects of neuroimmunology and Pain, with a focus in the disease MS.

We are at the Faculty of Medicine & Dentistry at the University of Alberta and are affiliated with:

The University of Alberta MS Center (MS Centre)

The Neuroscience and Mental Health Institute (NMHI)

Any interested prospective graduate students and postdoctoral fellows please contact:

Jason Plemel

Jason Plemel Google ScholarLink

Jason Plemel ResearchGateLink


Department SiteLink

Bradley Kerr

Bradley Kerr Google Scholar: Link

Bradley Kerr ResearchGateLink


Department SiteLink